Month: May 2025

Zahrawi Group, in collaboration with our esteemed partner Cepheid, was pleased to participate in the 5th POCT Advances Conference 2025, held at Cleveland Clinic Abu Dhabi, UAE.

The 5th Point of Care Testing (POCT) Advances Conference brought together leading experts, innovators, and healthcare professionals to explore the latest breakthroughs in rapid diagnostics and decentralized care. Under the theme “Advancing Care Anywhere: Pioneering POCT Innovations and Applications” the conference highlighted the critical role of POCT in enhancing patient outcomes, streamlining clinical workflows, and transforming healthcare delivery.

Our Lab team had the privilege of showcasing the GeneXpert Xpress IV-4 system as well as the Xpert® Xpress CoV-2/Flu/RSV plus test from our partner Cepheid, along with the HemoCue HbA1c 501 system and HemoCue WBC Diff from our partner HemoCue, presenting cutting-edge solutions for precise diagnostics and advanced healthcare analysis.

Zahrawi Group’s presence at the 5th POCT Advances Conference highlights our commitment to advancing healthcare through innovative point-of-care technologies. We aim to showcase our expertise, foster collaboration, and strengthen partnerships in improving patient outcomes.

Zahrawi Group participated in the 14th International Neonatology Conference, themed “Hottest Topics in Neonatal Medicine,” held at the Grand Hyatt Hotel in Abu Dhabi, UAE.

INC 2025 brought together leading experts from around the world to present cutting-edge developments in neonatal care. With a focus on critical areas such as birth complications, neonatal cardiology, nutrition, infections, surgery, neuroprotection, and medical ethics, the conference served as a dynamic platform for advancing clinical knowledge and fostering collaboration in the neonatal field.

Our Medical Team showcased advanced solutions from our esteemed partner, Medtronic, including Shiley™ Neonatal Tracheostomy and Endotracheal Tubes for airway management, INVOS™ Cerebral & Somatic Oximetry for early hypoxia detection, Capnostream™ 35 Respiratory Monitor for continuous ventilation monitoring, and Nellcor™ SoftCare™ and OxySoft™ Sensors for accurate SpO₂ monitoring in neonatal and pediatric patients.

Our presence highlighted our commitment to supporting neonatal healthcare through innovative solutions and close collaboration with medical professionals.